News: TRP Tissue Repair Receives Response From FDA Which Clarifies Path To Phase 3 Trials

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Sept 28 (Reuters) - Tissue Repair Ltd (TRP) :

    • RECEIVES RESPONSE FROM FDA WHICH CLARIFIES PATH TO PHASE 3 TRIALS
    • BELIEVES THAT IT WILL BE ABLE TO OBTAIN APPROVAL TO COMMENCE ITS PHASE 3 CLINICAL TRIALS IN 2023
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.5¢
Change
0.000(0.00%)
Mkt cap ! $16.62M
Open High Low Value Volume
27.5¢ 27.8¢ 27.5¢ $19.74K 71.66K

Buyers (Bids)

No. Vol. Price($)
3 56915 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 9000 1
View Market Depth
Last trade - 15.17pm 19/09/2025 (20 minute delay) ?
TRP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.